Histiocytosis Program

The Histiocytosis Program, located in the Texas Children's Cancer Center and Hematology Center, is associated with Baylor College of Medicine, one of the top medical schools in the country, and Texas Children's Hospital, the largest pediatric hospital in the United States.

The Texas Children's Cancer Center & Hematology Center has the unique capability of providing the highest "state of the art" treatment for children with the disorders listed below. Dr. McClain and a team of internal medicine physicians are also available to evaluate adults with LCH or Rosai Dorfman Syndrome and advise for appropriate treatment plans:

Langerhans cell histiocytosis (LCH)
(Histiocytosis X, eosinophilic granuloma)

Articles on LCH in children
Articles on LCH in adults

Hemophagocytic Lymphohistiocytosis (HLH)
(familial erythrophagocytic lymphohistiocytosis (FEL), virus-associated hemophagocytic syndrome (VAHS)

Articles on HLH

Sinus Histiocytosis with Massive Lymphadenopathy
(Rosai-Dorfman Syndrome)

Clinic Director:

Kenneth McClain, M.D. Ph.D. is the past president of the Histiocyte Society and has been treating patients with histiocytic disorders for over twenty years. He sees over 100 new LCH and HLH patients per year, and has over 300 active patients in the clinic.

He is a participant in the committees for LCH and HLH treatments in the Histiocyte Society and is the coordinator for the LCH-III, and LCH-CNS protocols in the United States.

Click on the link below to read an article by Dr. McClain from our quarterly eJournal, Perspectives on Childhood Cancer.

Subscribe to the eJournal here



Page modified on April 23, 2022